Published in J Am Coll Cardiol on August 12, 2014
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med (2016) 3.40
Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. JACC Cardiovasc Imaging (2015) 2.10
Importance of Angina in Patients With Coronary Disease, Heart Failure, and Left Ventricular Systolic Dysfunction: Insights From STICH. J Am Coll Cardiol (2015) 1.55
Cardiac surgery 2014 reviewed. Clin Res Cardiol (2015) 1.42
Balancing idealism with realism to safeguard the welfare of patients: The importance of Heart Team led decision-making in patients with complex coronary artery disease. Indian Heart J (2016) 0.75
In search of a solution from the STICH trial. J Am Coll Cardiol (2014) 0.75
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Eur J Heart Fail (2015) 0.75
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy. Curr Cardiol Rep (2016) 0.75
New Insights in the Diagnosis and Treatment of Heart Failure. Biomed Res Int (2015) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation (1987) 7.14
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol (2002) 3.97
Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation (2002) 3.47
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg (2007) 3.45
Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (2013) 3.15
A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med (1985) 2.49
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv (2014) 1.80
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation (2005) 1.59
Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg (2006) 1.42
Coronary artery bypass grafting in patients with low ejection fraction. Circulation (2005) 1.36
Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J (2012) 1.33
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol (2004) 1.18
Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. Circ Heart Fail (2013) 1.04
Underestimating medical therapy for coronary disease... again. N Engl J Med (2011) 0.95
Long term prognosis after CABG in relation to preoperative left ventricular ejection fraction. Int J Cardiol (2000) 0.86
The world post-STICH: is this a "Game Changer?" A non-invasive cardiologist's perspective-revascularization is the treatment of choice only in patients who fail medical therapy. Prog Cardiovasc Dis (2013) 0.82
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33
Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. JACC Cardiovasc Imaging (2015) 2.10
The genetic architecture of type 2 diabetes. Nature (2016) 1.43
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC Heart Fail (2014) 1.41
Cardiovascular research publications from Latin America between 1999 and 2008. A bibliometric study. Arq Bras Cardiol (2015) 1.24
Global cardiovascular research output, citations, and collaborations: a time-trend, bibliometric analysis (1999-2008). PLoS One (2013) 1.09
Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study. Int J Cardiol (2015) 0.82
Footprint and imprint: an ecologic time-trend analysis of cardiovascular publications in general and specialty journals. Glob Heart (2014) 0.81
Cardiac rehabilitation in India. Prog Cardiovasc Dis (2013) 0.81
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes. Am Heart J (2014) 0.80
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. Am Heart J (2013) 0.78
Is the Association between Vitamin D and Cardiovascular Disease Risk Confounded by Obesity? Evidence from the Andhra Pradesh Children and Parents Study (APCAPS). PLoS One (2015) 0.77
Impact of omega-6 fatty acids on cardiovascular outcomes: A review. J Preventive Cardiol (2013) 0.77
Long-term support of patients receiving a left ventricular assist device for advanced heart failure: a follow-up analysis of the Registry to Evaluate the HeartWare Left Ventricular Assist System. Eur J Cardiothorac Surg (2016) 0.76
A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. Diabetes (2017) 0.75
Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis. J Pharm Policy Pract (2016) 0.75
Cardiovascular Disease and Health Care System Impact on Functionality and Productivity in Argentina: A Secondary Analysis. Value Health Reg Issues (2016) 0.75
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial. Lancet Glob Health (2019) 0.75
Associations Between Sociodemographic Characteristics, Pre Migratory and Migratory Factors and Psychological Distress Just After Migration and After Resettlement: The Indian Migration Study. Indian J Soc Psychiatry (2015) 0.75
Insights from a study by the ESC cardiologists of tomorrow nucleus: the junior cardiologists’ research reveals that the ESC is well regarded by young cardiologists but there is room for improving its appeal. Eur Heart J (2012) 0.75
Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice. Eur J Cardiothorac Surg (2016) 0.75
Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population. PLoS One (2022) 0.75